Fundraising Fox
/Companies
Sign in

LivFul

Temple, US · Founded 2021 · 1 known investors

Find your way into LivFul

587 people in our graph share verified history with the LivFul team — schools, employers, funds. One of them is your warm intro.

Luke Roushunlockedknows John Manwell · together at Global BioDiagnostics Corp. (overlapped)
knows the team · via PSINet
×10knows the team · via AT&T

LivFul develops and distributes safe medicines and health solutions aimed at diseases affecting the global south, including neglected tropical diseases (NTDs). The company focuses on health access and clinical validation for developing countries and emerging markets.

BiotechHealthtechImpact & Social Good

Founders & leadership

LivFul was founded in 2021 by Andy Mahler.

AM
Andy MahlerFounderAndy Mahler has held management and individual contributor roles spanning Fortune 500 companies and startups across technology, healthcare, telecommunications, consumer goods, and biotechnology sectors, with experience in product management, engineering, business development, and operations.
HB
Hogan BasseyExecutive
MEMatt Elsberry
Matt ElsberryExecutiveMatt Elsberry worked in nonprofit leadership roles and as VP of Organization Development for a Southeast Asian conglomerate before founding the Kingdom Entrepreneurship Academy with Indonesian partners. He is now an Executive Officer and Director at LivFul, a life science company focused on expanding access to health solutions.
JMJohn Manwell
John ManwellExecutiveJohn Manwell is an Executive Officer and Director at LivFul, which develops insect repellent products for disease prevention. He has background experience in fiber optic sensing technology and general management, with expertise in team building and international operations.
MNMichael Norman
Michael NormanExecutiveMichael Norman is an executive officer and director at LivFul, a life science company focused on developing and distributing health products and solutions, particularly for underserved populations.
FY
Francis YipExecutive

Board

CT
Carl ThongBoard director
YN
Yaw NsarkohBoard director
KM
Kris MaynardBoard director
AB
Andrew BarlowBoard director
WL
Wesley LyonsBoard director
DR
Dave RaeBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$10.1M disclosed across 4 rounds · 2021–2025

▶$250KraisedDec 2025 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Hogan BasseyExecutive Officer, Director
  • Matt ElsberryExecutive Officer, Director
  • Yaw NsarkohDirector
  • John ManwellExecutive Officer, Director
  • Kris MaynardDirector
  • Michael NormanExecutive Officer, Director
  • Andrew BarlowDirector
  • Carl ThongDirector
Offering amount
$26M
Amount sold
$250K
Minimum investment
$250K
First sale
Dec 2025
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$125KraisedJun 2024 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael NormanExecutive Officer, Director
  • Yaw NsarkohExecutive Officer, Director
  • Wesley LyonsDirector
  • Hogan BasseyExecutive Officer, Director
  • John ManwellExecutive Officer, Director
  • Kris MaynardDirector
  • Kevin EngelExecutive Officer, Director
  • Matt ElsberryExecutive Officer, Director
Offering amount
$6.5M
Amount sold
$125K
First sale
May 2024
Incorporated
Corporation, Texas, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedApr 2023 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Wesley LyonsDirector
  • Francis YipExecutive Officer, Director
  • John ManwellExecutive Officer, Director
  • Michael NormanExecutive Officer, Director
  • Dave RaeDirector
  • Hogan BasseyExecutive Officer, Director
  • Matt ElsberryExecutive Officer, Director
Offering amount
$5M
Amount sold
$3.1M
First sale
May 2022
Incorporated
Corporation, Texas, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.7MraisedMar 2021 · 60 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dave RaeDirector
  • Francis YipExecutive Officer, Director
  • Matt ElsberryExecutive Officer, Director
  • Hogan BasseyExecutive Officer, Director
  • John ManwellExecutive Officer, Director
  • Michael NormanExecutive Officer, Director
Offering amount
$10.7M
Amount sold
$6.7M
First sale
Mar 2021
Incorporated
Corporation, Texas, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

LivFul: Justice Through Health Innovation — Impact Foundationimpactfoundation.org · Aug 2020

Frequently asked questions

What does LivFul do?
LivFul develops and distributes safe medicines and health solutions aimed at diseases affecting the global south, including neglected tropical diseases (NTDs). The company focuses on health access and clinical validation for developing countries and emerging markets.
Who founded LivFul?
LivFul was founded by Andy Mahler in 2021.
Who are LivFul's investors?
LivFul's investors include Eagle Venture.
How much funding has LivFul raised?
LivFul has disclosed $10.1M raised across 4 rounds.
Where is LivFul headquartered?
LivFul is headquartered in Temple, US.